NATH BIOGENES (INDIA)
Back to Income Statement
|
NATH BIOGENES (INDIA) Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹20.31 | ₹20.85 | ₹18.43 | ₹-35.46 | ₹7.34 |
What is the latest Earnings Per Share (EPS) of NATH BIOGENES (INDIA) ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹20.31 |
| Mar2024 | ₹20.85 |
| Mar2023 | ₹18.43 |
| Mar2022 | ₹-35.46 |
| Mar2013 | ₹7.34 |
How is Earnings Per Share (EPS) of NATH BIOGENES (INDIA) Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹20.31 | -2.59 | |
| Mar2024 | ₹20.85 | 13.13 | |
| Mar2023 | ₹18.43 | Positive | |
| Mar2022 | ₹-35.46 | Negative | |
| Mar2013 | ₹7.34 | - | |
Compare Earnings Per Share (EPS) of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹319.4 Cr | 10.2% | 17.9% | 11.2% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹10,668.5 Cr | 2.7% | 0.3% | -16.3% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,755.5 Cr | -0.1% | 14.1% | -32.8% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,238.8 Cr | 8.9% | 31% | -6.2% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,052.8 Cr | 1.9% | 22.3% | -12.9% | Stock Analytics | |
| INDO US BIOTECH | ₹216.6 Cr | 0.8% | 8.9% | -32.3% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | 10.2% |
17.9% |
11.2% |
| SENSEX | 2.4% |
3.2% |
5.8% |
You may also like the below Video Courses